Company

Cleothena is a privately held, clinical-stage biotechnology company.

The company operates a high-efficiency model designed to accelerate the translation of scientific discovery into clinical validation through tightly integrated development pathways.

Infrastructure & Strategic Partnerships

Cleothena maintains a focused and high-quality operational infrastructure to support its clinical programs.

The company’s intellectual property portfolio is managed by the international IP firm Carpmaels & Ransford (UK), reflecting a commitment to rigorous protection and global positioning of its assets.

Cleothena collaborates with selected global partners across formulation, clinical development, and regulatory execution.